Yu Shyr Archives
VUMC’s Pietenpol, Shyr named AACR Fellows
Mar. 22, 2022—Vanderbilt's Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.
Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy
Jan. 14, 2022—A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.
Method proposed to correct misinterpretations of long-term survival rates for immunotherapies
Apr. 15, 2021—Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.
Multinational consortium reports COVID-19 impact on cancer patients
May. 28, 2020—People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from a multinational perspective. The data on more than 900 patients, published May 28 in The Lancet and simultaneously presented at ASCO20 Virtual, also revealed cancer-specific factors associated with increased mortality.
Research team awarded $9 million to study extracellular RNA in colorectal cancer
Apr. 9, 2020—The NCI program project grant is supporting multiple projects that aim to define fundamental biological principles about extracellular RNA signaling and the development and aggressiveness of colorectal cancer, the second leading cause of cancer death in the United States.
Lewis’ Discovery Lecture
Jan. 18, 2018—Clinical trials expert Roger Lewis, MD, PhD, right, poses with Vanderbilt’s Yu Shyr, MD, following his recent Discovery Lecture. Lewis is chair of Emergency Medicine at Harbor-UCLA Medical Center in Los Angeles.
Shyr named chair of Department of Biostatistics
Jul. 20, 2017—Yu Shyr, Ph.D., Harold L. Moses Professor of Cancer Research and director of the Vanderbilt Center for Quantitative Sciences, has been named chair of Vanderbilt’s Department of Biostatistics. He will assume the post Sept. 1.
Nine Vanderbilt faculty members elected AAAS fellows
Nov. 25, 2016—Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.
VICC investigators in spotlight at AACR conference
May. 19, 2016—A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.
IOM study calls for better evidence for biomarker tests
Mar. 10, 2016—Biomarker tests that help determine which patients may benefit from molecularly targeted therapies need better evidence and oversight to improve their effectiveness and availability, according to a study by the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine.
Moses, Shyr named to Institute of Medicine cancer therapies panel
Mar. 5, 2015—Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.
Event celebrates 12 Vanderbilt endowed chair holders
Aug. 30, 2013—Twelve Vanderbilt University faculty members named to endowed chairs were lauded for their extraordinary academic achievements during an Aug. 28 celebration.
